These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20022345)

  • 1. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
    Paslakis G; Luppa P; Gilles M; Kopf D; Hamann-Weber B; Lederbogen F; Deuschle M
    J Psychiatr Res; 2010 Jun; 44(8):556-60. PubMed ID: 20022345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
    Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
    Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
    Hsiao CC
    Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings.
    Assies J; Visser I; Nicolson NA; Eggelte TA; Wekking EM; Huyser J; Lieverse R; Schene AH
    Psychiatry Res; 2004 Sep; 128(2):117-22. PubMed ID: 15488954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
    Schilling C; Gilles M; Blum WF; Daseking E; Colla M; Weber-Hamann B; Lederbogen F; Krumm B; Heuser I; Wudy SA; Kopf D; Deuschle M
    J Clin Psychopharmacol; 2013 Feb; 33(1):99-103. PubMed ID: 23277262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
    Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
    Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
    Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ; O'Keane V; Miell JP
    Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
    Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 15. An open trial of venlafaxine for the treatment of late-life atypical depression.
    Roose SP; Miyazaki M; Devanand D; Seidman S; Fitzsimmons L; Turret N; Sackeim H
    Int J Geriatr Psychiatry; 2004 Oct; 19(10):989-94. PubMed ID: 15449363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
    Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
    J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone sulfate (DHEA-S) and Alzheimer's dementia in older subjects.
    Bo M; Massaia M; Zannella P; Cappa G; Ferrario E; Rainero I; Arvat E; Giordano R; Molaschi M
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1065-70. PubMed ID: 16977674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.